| Dual Anti-CD22/CD19 Chimeric Antigen Receptor-directed T Cells (CART2219.1) for Relapsed Refractory B-Lineage Leukaemia (NCT05429905) | KK Women's and Children's Hospital | 2022-07-18 |
| CAR-Multicenter Analysis (CAR-MA): Retrospective Study to Characterize CAR T-cell Outcomes and Related Toxicities in Children and Young Adults With B-ALL (NCT05440409) | National Cancer Institute (NCI) | 2021-10-14 |
| CARTALL: Chimeric-Antigen Receptor (CAR) T-Cell Therapy for Relapsed/ Refractory T-Lineage Acute Lymphoblastic Leukaemia (NCT05043571) | National University Hospital, Singapore | 2021-09-08 |
| ALaCART-B: Acute Leukemia and Chimeric Antigen Receptor-T Cell Therapy for B-lymphoblastic Leukemia. (NCT05038696) | National University Hospital, Singapore | 2021-04-28 |
| N-Acetylcysteine vs Placebo as Adjunctive Treatment in Pediatric Leukemia (NCT05611086) | Teny Tjitra Sari | 2019-08-29 |
| PO Ixazomib in Combination With Chemotherapy for Childhood Relapsed or Refractory Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (NCT03817320) | Therapeutic Advances in Childhood Leukemia Consortium | 2019-02-12 |
| Vincristine Sulfate Liposome Injection (Marqibo®) in Combination With UK ALL R3 Induction Chemotherapy (NCT02879643) | Therapeutic Advances in Childhood Leukemia Consortium | 2017-01-31 |
| Study of the Tocilizumab Optimization Timing for CART19 Associated Cytokine Release Syndrome (NCT02906371) | University of Pennsylvania | 2016-08-01 |
| A Trial of Temsirolimus With Etoposide and Cyclophosphamide in Children With Relapsed Acute Lymphoblastic Leukemia and Non-Hodgkins Lymphoma (NCT01614197) | Therapeutic Advances in Childhood Leukemia Consortium | 2015-07-03 |
| A Phase I Study of 5-Azacytidine in Combination With Chemotherapy for Children With Relapsed or Refractory ALL or AML (NCT01861002) | Therapeutic Advances in Childhood Leukemia Consortium | 2013-05-22 |
| AC220 for Children With Relapsed/Refractory ALL or AML (NCT01411267) | Therapeutic Advances in Childhood Leukemia Consortium | 2011-09-01 |
| A Study Of Panobinostat In Children With Refractory Hematologic Malignancies (NCT01321346) | Therapeutic Advances in Childhood Leukemia Consortium | 2011-03-01 |
| Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL (NCT01896752) | Rigshospitalet, Denmark | 2011-03-01 |
| EZN-3042 Administered With Re-induction Chemotherapy in Children With Relapsed Acute Lymphoblastic Leukemia (ALL) (NCT01186328) | Therapeutic Advances in Childhood Leukemia Consortium | 2010-08-24 |
| Effects of Methylphenidate on Attention Deficits in Childhood Cancer Survivors (NCT01100658) | University of Minnesota | 2010-05-01 |
| A Safety and Tolerability Study of Clofarabine, Etoposide, Cyclophosphamide, PEG-asparaginase, and Vincristine in Pediatric Acute Lymphoblastic Leukemia (ALL) (NCT00991133) | Genzyme, a Sanofi Company | 2009-10-01 |
| ALL-SCT BFM International- HSCT in Children and Adolescents With ALL (NCT01423500) | St. Anna Kinderkrebsforschung | 2007-01-01 |
| Allogeneic Stem Cell Transplantation in Children and Adolescents With Acute Lymphoblastic Leukaemia (NCT01423747) | St. Anna Kinderkrebsforschung | 2003-07-01 |